-
Part 2 | Session 5 FAME 3: FFR-Guided PCI Vs CABG in Pts With Multivessel CAD
-
Part 2 | Session 9 FLASH Trial: US Outcomes of the FlowTriever for Pulmonary Embolism
-
Part 1 | Session 1 TCT 22 Late-breaking Science Wrap-up
-
Part 1 | Session 2 TCT 22 Late-breaking Science Preview
-
Part 2 | Session 1 PROTECTED-TAVR: Sentinel® Stroke Protection System During TAVR
-
Part 2 | Session 2 RADIANCE II: Paradise Renal Denervation in Pts With Hypertension
Stay up-to-date with our regular review series, View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this #TCT2022 edition they provide a short analysis of the most pertinent data from 15 late-breaking science presentations.
Short, accessible Expert Interviews were conducted with investigators focusing on study design, key results and applicability of the latest data.
More from this programme
Faculty Biographies

Dhanunjaya Lakkireddy
Medical Director and Professor of Medicine
Dr Dhanunjaya Lakkireddy is the Medical Director at Kansas City Heart Rhythm Institute and a Professor of Medicine at the University of Missouri, Columbia. As a trained cardiologist he specialises in the research and education of electrophysiology. He is a Chairman of the ACC Electrophysiology Council as well as a member of the Program Committee in the Heart Rhythm Society.
Dr Lakkireddy has received multiple awards and recognitions, including the Professional Leader of the Year from the Asian Chamber of Commerce, Prevention Magazine Integrative Medicine Award, and Ingram's Heroes in Health Care Award.
He continues to serve as the principal investigator for clinical trials and has published more than 350 articles in the field of electrophysiology. Alongside writing articles, Dr. Lakkireddy is the Editor-in-Chief for the Journal of Atrial Fibrillation, Deputy Editor for the Journal of Interventional Electrophysiology, and editorial board member and reviewer for more than…